BioSpace News Archive

Onions ‘Cut Heart Disease Risk’

November 5, 2007
·
1 min read
Deals

Boston Scientific Corporation Agrees to Sell Units for $750 Million

November 5, 2007
·
5 min read
Deals

Genoptix, Inc. Announces Closing of IPO and Exercise in Full of Underwriters’ Over-Allotment Option

November 5, 2007
·
2 min read
Drug Development

Keryx Biopharmaceuticals Announces Positive Preliminary Phase 2 Data on KRX-0401

November 5, 2007
·
7 min read
Drug Development

Medivation, Inc.'s MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial

November 5, 2007
·
5 min read
Business

ImaRx Therapeutics and Royal Philips Electronics N.V. to Collaborate on Potential Treatment for Ischemic Stroke Using Microbubbles and Ultrasound

November 5, 2007
·
1 min read
Drug Development

Phase 2 Trial Results for Exelixis, Inc.’ XL784 Presented at the 2007 American Society of Nephrology Conference

November 5, 2007
·
5 min read
Drug Development

Positive Results From Peregrine Pharmaceuticals, Inc.'s Bavituximab Phase l HCV Trial Presented at AASLD Meeting

November 5, 2007
·
6 min read
Drug Development

Daiichi Sankyo, Inc. and Eli Lilly and Company Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel

November 5, 2007
·
5 min read
Drug Development

Eli Lilly and Company In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack

November 5, 2007
·
9 min read